Prospective nanoparticle treatments for lymphangioleiomyomatosis.

Landh, Emelie; Wang, Roger; Moir, Lyn M; Traini, Daniela; Young, Paul M; Ong, Hui Xin

Landh, Emelie; Wang, Roger; Moir, Lyn M; Traini, Daniela; Young, Paul M; Ong, Hui Xin.

Afiliación

Landh E; Respiratory Technology Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.
Wang R; Respiratory Technology Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.
Moir LM; Respiratory Technology Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.
Traini D; Respiratory Technology Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.
Young PM; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Sydney, Australia.
Ong HX; Respiratory Technology Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.

Expert Opin Drug Deliv ; 19(1): 75-86, 2022 01.

Article en En | MEDLINE | ID: mdl-35043744

Asunto(s)

Linfangioleiomiomatosis; Nanopartículas; Humanos; Lípidos/uso terapéutico; Liposomas; Linfangioleiomiomatosis/tratamiento farmacológico; Sirolimus/uso terapéutico

Palabras clave

Lymphangioleiomyomatosisi; inhalation; lymphatic system; nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfangioleiomiomatosis / Nanopartículas Límite: Humans Idioma: En Revista: Expert Opin Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google